Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2026-01-23 @ 5:01 PM
Study NCT ID:
NCT05386459
Status:
COMPLETED
Last Update Posted:
2022-05-27
First Post:
2022-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Use of the Drug Ingaron in Patients With COVID-19
Sponsor:
SPP Pharmaclon Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2GAMMACOVID-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None